GlassScriptPhysician profile
Tammy Danise Smith
NPI 1841675253
$1,344.84
in general payments reported to CMS, 2019-2025
15 companies · $1,121 in 2025
The $1,121 reported for 2025 was more than what 86% of Adult Health (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $186).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $25.97 · 2023: $16.30 · 2024: $181 · 2025: $1,121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,220 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,219.87 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $293.15 | 2024-2025 | Farxiga, Breztri, Airsupra |
| Alexion Pharmaceuticals, INC. | $258.02 | 2025 | Ultomiris |
| Astellas Pharma US INC | $175.64 | 2025 | Veozah |
| Novo Nordisk INC | $105.44 | 2025 | Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $95.72 | 2024-2025 | Jardiance |
| Abbvie INC. | $92.87 | 2024-2025 | |
| Lilly USA, LLC | $64.26 | 2021-2025 | Zepbound, Mounjaro |
| Exact Sciences Corporation | $52.26 | 2025 | The Cologuard Plus Collection Kit |
| Otsuka America Pharmaceutical, INC. | $51.15 | 2025 | Rexulti |
| Pfizer INC. | $41.02 | 2024-2025 | |
| Glaxosmithkline, LLC. | $39.69 | 2025 | Trelegy Ellipta |
| Axsome Therapeutics, INC. | $30.95 | 2025 | Auvelity |
| Medline Industries LP | $16.30 | 2023 | |
| Antares Pharma, INC. | $15.03 | 2025 | Xyosted |
| Eisai INC. | $13.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tammy Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.